Sutro Biopharma develops antibody drug conjugates, a type of cancer treatment, for patients with solid tumors. It last closed at $8.60 on Nov 20, down 1.38% on the day. The next earnings report for STRO is expected around Mon, Mar 22, 2027, after the close. For the quarter ended Sep 2026, STRO reported EPS of -$1.90 on revenue of $9.1M, with revenue down 6.1% from a year ago. Over its last 8 reports the stock moved an average of 10.9% the session after earnings.
AI Auto Pilots
Is STRO in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold STRO.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on STROStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
STRO · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 9% below its 20 day and 42% below its 50 day average. It is 163% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 34), near oversold. The nearest support is the swing low (Nov 16) at $8.33, and the nearest resistance the Pivot at $8.69.
Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityNormal, 10.7%/day
Key levels
$43.8552 week high+409.9%
$22.61200 day average+162.9%
$17.85100 day average+107.6%
$12.2250 day average+42.1%
$10.77Swing high (Nov 10)+25.2%
$9.3620 day average+8.8%
$8.99Pivot R1+4.5%
$8.69Pivot+1.0%
$8.60Last close
$8.33Swing low (Nov 16)−3.1%
$8.30Pivot S1−3.5%
$7.1552 week low−16.9%
Indicators
RSI (14)
34.42
Weak, oversold below 30
Neutral
MACD
-0.95
Above its signal line
Bullish
Stochastic
11.3
Near the bottom of its range
Oversold
ADX (14)
42.9
Strong downtrend
Williams %R
-88.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-100.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−10.6%
Change over 10 sessions
Bearish
ATR (14)
$0.92
Typical daily range, 10.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 37.1%/day
Key levels
$43.8552 week high+409.9%
$22.61200 day average+162.9%
$17.85100 day average+107.6%
$12.2250 day average+42.1%
$10.77Swing high (Nov 10)+25.2%
$9.3620 day average+8.8%
$8.99Pivot R1+4.5%
$8.69Pivot+1.0%
$8.60Last close
$8.33Swing low (Nov 16)−3.1%
$8.30Pivot S1−3.5%
$7.1552 week low−16.9%
Indicators
RSI (14)
29.40
Oversold below 30
Oversold
MACD
-4.00
Below its signal line
Bearish
Stochastic
7.0
Near the bottom of its range
Oversold
ADX (14)
33.5
Trending down
Williams %R
-96.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-106.9
Oversold below −100, overbought above 100
Oversold
Rate of change
−49.0%
Change over 10 sessions
Bearish
ATR (14)
$3.19
Typical daily range, 37.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for STRO
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how STRO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow STRO usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for STROHow many large options trades hit STRO, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in STRO in the last 90 days.
From SEC Form 4 filings by STRO's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether STRO is in one of them and how their past STRO trades turned out.
Sutro Biopharma develops antibody drug conjugates, or ADCs, which are cancer treatments that link antibodies to cell-killing drugs. It uses its XpressCF protein synthesis platform to make these protein therapies, mainly for cancers. Its lead candidate, STRO-004, is in clinical trials for solid tumors. The company also works with pharmaceutical and biotechnology companies in oncology through research collaborations, and it is based in South San Francisco, California.